Cargando…
Voluntary exercise reduces both chemotherapy-induced neuropathic nociception and deficits in hippocampal cellular proliferation in a mouse model of paclitaxel-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side-effect of all major chemotherapeutic agents. Here, we explored efficacy of voluntary exercise as a nonpharmacological strategy for suppressing two distinct adverse side effects of chemotherapy treatment. We evaluated wh...
Autores principales: | Slivicki, Richard A., Mali, Sonali S., Hohmann, Andrea G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739464/ https://www.ncbi.nlm.nih.gov/pubmed/31528755 http://dx.doi.org/10.1016/j.ynpai.2019.100035 |
Ejemplares similares
-
Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel‐induced peripheral neuropathy
por: Kalynovska, Nataliia, et al.
Publicado: (2020) -
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
por: Rahn, Elizabeth J, et al.
Publicado: (2014) -
Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo
por: Slivicki, Richard A., et al.
Publicado: (2016) -
The Antinociceptive Responses of MTDZ to Paclitaxel−Induced Peripheral Neuropathy and Acute Nociception in Mice: Behavioral, Pharmacological, and Biochemical Approaches
por: da Motta, Ketlyn P., et al.
Publicado: (2023) -
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)